PRF Technologies (PRFX) Operating Expenses (2020 - 2024)

PRF Technologies (PRFX) posted quarterly Operating Expenses of -$16.8 million for Q2 2024, down 634.59% year-on-year from $3.1 million in Q3 2023, and down 529.42% on a QoQ basis from $3.9 million in Q1 2024.

PRF Technologies (PRFX) Operating Expenses (2020 - 2024) Analysis & Trends

PRF Technologies (PRFX) has reported Operating Expenses for 5 consecutive years, with -$16.8 million the latest figure, recorded in Q2 2024.

  • Quarterly Operating Expenses fell 634.59% year-over-year to -$16.8 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was -$16.8 million (down 333.29% YoY) and the FY2025 annual result came in at $4.1 million, down 71.74% from the prior year.
  • Operating Expenses eased to -$16.8 million in Q2 2024 per PRFX's latest filing, from $3.9 million in the prior quarter.
  • Over the last five years, Operating Expenses for PRFX reached as high as $14.5 million in Q4 2022 and fell as low as -$16.8 million in Q2 2024.
  • A 5-year average of $802166.7 and a median of -$129000.0 in 2020 frame the typical range for Operating Expenses.
  • Annual changes were most pronounced in 2022 — Operating Expenses plunged 1742.11% — and 2023, when it surged 976.88%.
  • Year by year, Operating Expenses stood at $2.7 million in 2020, then soared by 375.07% to $12.7 million in 2021, then climbed by 14.26% to $14.5 million in 2022, then tumbled by 37.67% to $9.0 million in 2023, then plunged by 286.45% to -$16.8 million in 2024.
  • According to Business Quant data, Operating Expenses over the past three periods registered -$16.8 million, $3.9 million, and $9.0 million for Q2 2024, Q1 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.00 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 788.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 12.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 455.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.24 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 621.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 494.00 Mn
10 PRF Technologies 745,168.93 451,168.93 - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -16.83 Mn
Mar 31, 2024 3.92 Mn
Dec 31, 2023 9.03 Mn
Sep 30, 2023 -174,000.00
Jun 30, 2023 3.15 Mn
Mar 31, 2023 -2.42 Mn
Dec 31, 2022 14.48 Mn
Sep 30, 2022 -4.94 Mn
Jun 30, 2022 -359,000.00
Mar 31, 2022 -312,000.00
Dec 31, 2021 12.68 Mn
Sep 30, 2021 -5.23 Mn
Jun 30, 2021 -256,000.00
Mar 31, 2021 19,000.00
Dec 31, 2020 2.67 Mn
Sep 30, 2020 -830,000.00
Jun 30, 2020 -66,000.00
Mar 31, 2020 -84,000.00